Additionally, we identified numerous non-ribosomal proteins as therapeutic targets for HER2+ BC, including SOD1, PPP4C, PSMB7, PSMD3, TIMM13, NOP10, YBX1, TXN, PGK1, MED1, and HMGA1. Here, HMGA1 is linked to breast cancer.